GENEVA, July 2 -- SEEGENE, INC. filed a patent application (KR2025/021913) for “MUTANT M-MLV REVERSE TRANSCRIPTASE”. With publication no. WO/2026/135182, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 9/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....